These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 10677121)

  • 1. Severity of liver disease in hepatitis C infection contracted through injecting drug use.
    Ostapowicz G; Bell SJ; Desmond PV
    Aust N Z J Med; 1999 Dec; 29(6):776-81. PubMed ID: 10677121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 1: Critical hepatitis C and injector data.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):243-65; discussion 279-85. PubMed ID: 11437088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HCV genotypes and age distribution in patients of Vienna and surrounding areas.
    Haushofer AC; Kopty C; Hauer R; Brunner H; Halbmayer WM
    J Clin Virol; 2001 Jan; 20(1-2):41-7. PubMed ID: 11163582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of hepatitis C in an ethnically diverse HIV-1-infected cohort in south London.
    Mohsen AH; Murad S; Easterbrook PJ
    HIV Med; 2005 May; 6(3):206-15. PubMed ID: 15876288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.
    Bellentani S; Pozzato G; Saccoccio G; Crovatto M; Crocè LS; Mazzoran L; Masutti F; Cristianini G; Tiribelli C
    Gut; 1999 Jun; 44(6):874-80. PubMed ID: 10323892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in hepatitis C-related liver disease in a large clinic population.
    Ostapowicz G; Dallinger M; Bell SJ; Strasser SI; Watson KJ; Slavin J; Santamaria J; Desmond PV
    Intern Med J; 2001 Mar; 31(2):90-6. PubMed ID: 11480484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of hepatitis C in decentralised versus centralised drug substitution programmes and minimally invasive point-of-care tests to close gaps in the HCV cascade.
    Bregenzer A; Conen A; Knuchel J; Friedl A; Eigenmann F; Näf M; Ackle P; Roth M; Fux CA
    Swiss Med Wkly; 2017; 147():w14544. PubMed ID: 29185250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus acquisition among injecting drug users: a cohort analysis of a national repeated cross-sectional survey of needle and syringe program attendees in Australia, 1995-2004.
    Falster K; Kaldor JM; Maher L;
    J Urban Health; 2009 Jan; 86(1):106-18. PubMed ID: 18979201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nosocomial risk factors of hepatitis C infection. A multicenter study in a hospital-based population].
    Maugat S; Astagneau P; Thibault V; Desruennes E; Baffoy N; Desenclos JC; Brücker G
    Rev Epidemiol Sante Publique; 2003 Jun; 51(3):301-8. PubMed ID: 13130210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of alcohol in the progression of liver disease caused by hepatitis C virus infection.
    Ostapowicz G; Watson KJ; Locarnini SA; Desmond PV
    Hepatology; 1998 Jun; 27(6):1730-5. PubMed ID: 9620350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C virus type 1b (II) infection in France and Italy. Collaborative Study Group.
    Nousbaum JB; Pol S; Nalpas B; Landais P; Berthelot P; Bréchot C
    Ann Intern Med; 1995 Feb; 122(3):161-8. PubMed ID: 7810932
    [TBL] [Abstract][Full Text] [Related]  

  • 13.  Natural history of hepatitis C virus infection in a cohort of asymptomatic post-transfused subjects.
    Reggiardo MV; Fay F; Tanno M; García-Camacho G; Bottaso O; Ferretti S; Godoy A; Guerrita C; Paez M; Tanno F; Ruffinengo O; Benetti S; García Borrás SE; Rossi MC; Vorobioff J; Bessone F; Tanno H
    Ann Hepatol; 2012; 11(5):658-66. PubMed ID: 22947526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between histologic staging, hepatitis C virus genotypes and clinical features in HCV chronic hepatitis: evidence of a new pattern.
    Di Tommaso L; Macchia S; Morandi L; Leoncini S; Pession A; Dal Monte PR; Foschini MP
    Int J Surg Pathol; 2003 Jul; 11(3):197-204. PubMed ID: 12894351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Projecting severe sequelae of injection-related hepatitis C virus epidemic in the UK. Part 2: Preliminary UK estimates of prevalent injection-related hepatitis C carriers, and derivation of progression rates to liver cirrhosis by gender and age at hepatitis C virus infection.
    Bird SM; Goldberg DJ; Hutchinson SJ
    J Epidemiol Biostat; 2001; 6(3):267-77; discussion 279-85. PubMed ID: 11437089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
    Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
    J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver transplantation for hepatitis C-associated cirrhosis in a single Australian centre: referral patterns and transplant outcomes.
    Levy MT; Chen JJ; McGuinness PH; Koorey D; Sheil AG; McCaughan GW
    J Gastroenterol Hepatol; 1997 Jun; 12(6):453-9. PubMed ID: 9195404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
    Hallinan R; Byrne A; Amin J; Dore GJ
    J Gastroenterol Hepatol; 2005 Jul; 20(7):1082-6. PubMed ID: 15955218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of hepatitis C virus RNA and liver histology in chronic type C hepatitis.
    Gordon SC; Kodali VP; Silverman AL; Dmuchowski CF; Urdea MS; Chan CS; Wilber JC
    Am J Gastroenterol; 1994 Sep; 89(9):1458-61. PubMed ID: 8079919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C in injecting drug-using women during and after pregnancy.
    Latt NC; Spencer JD; Beeby PJ; McCaughan GW; Saunders JB; Collins E; Cossart YE
    J Gastroenterol Hepatol; 2000 Feb; 15(2):175-81. PubMed ID: 10735542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.